We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

Johnson Controls International plc (NYSE: JCI) is a leading global engineering company specializing in building technology ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson aims to streamline operations by selling its stroke care business, Cerenovus, valued at $1B+.

For the first time in 18 years, Dustin Johnson is an equipment free agent. Johnson’s contract with TaylorMade was not extended at the end of last year, according to multiple outlets that received ...

Johnson & Johnson executive praises China's biotech innovation in oncology and immunology, highlighting potential future ...

Dustin Johnson's TaylorMade endorsement deal ended in 2024 and has not been extended, making the two-time major winner an ...

Dustin Johnson and TaylorMade end a lengthy run, bringing with it questions about the endorsement value of LIV players ...